This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 499196
Submitted by lobbyist on: August 28, 2015 10:17:24 AM
Accepted by Registrar on: August 28, 2015 10:29:36 AM
Designated Filer Information
Dawson, Robert W |
17300 Trans-Canada Highway | |
Kirkland, QC, H9J 2M5
|
250-472-7601 |
Canada |
Organization Information
Pfizer Canada |
Pfizer Inc. is one of the world's leading research based pharmaceutical companies. Pfizer discovers and develops life-saving and life-enhancing medications and vaccines for humans. We also provide cost-saving off-patented medicines. The company's Canadian operation, Pfizer Canada Inc., is one of the largest private contributors to health research in Canada and also donates millions of dollars annually to support community initiatives. |
17300 Trans-Canada Highway | |
Kirkland, QC, H9J 2M5
|
250-472-7601 |
Canada |
Relevant Affiliates
Type:
Business Name | Mailing Address | Contact Information |
---|---|---|
Pfizer Inc. |
235 East 42nd Street
New York, NY 10017 United States of America |
Phone: 514-426-6888 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
August 28, 2015 | |
February 24, 2016 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Present information regarding the cost effectiveness of public health funding for adult CAP (community acquired pneumonia) and the efficacy profile of Pfizer's vaccine Prevnar 13
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
MLA | Plecas, Darryl | Abbotsford South | November 23, 2015 |
Health
Development, establishment, amendment or termination of any program, policy or decision
The Ministry of Health has indicated a desire to expand and modernize the Reference Drug Program. The purpose of my lobby activities will be to gain additional details on the planned changes, provide input on how to protect innovation and patient choice, and work towards acceptable solutions that serve the financial targets of the Ministry.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Lake, Terry | Minister of Health | August 28, 2015 |
Minister | Virk, Amrik | Minister of Technology, Innovation and Citizens' Services | August 28, 2015 |
Minister | Wilkinson, Andrew | Minister of Advanced Education | August 28, 2015 |
MLA | Stilwell, Moira | Vancouver-Langara | September 14, 2015 |
MLA | Sultan, Ralph | West Vancouver-Capilano | September 14, 2015 |